Medical Research
Follow Medical Research in the Factlen app and get an alert when there is news. Get the app
- All Health
- Nutrition & Diet
- Supplements
- Mental Health
- Sleep
- Longevity
- Medicine
- Medications & Treatments
- Conditions & Diseases
- Hormones & Endocrinology
- Skincare
- Dental Health
- Family Health
- Children's Health
- Men's Health
- Women's Health
- Aging & Geroscience
- Biohacking
- Alternative Medicine
- Public Health
- Medical Research
- Preventive Wellness
- Healthy Habits
Metabolic Health
First-in-Class GLP-1 Antagonist Slashes Hypoglycemia Risk by 55% in Phase 3 Trial for Post-Bariatric Surgery Complication
6 sources · 64d ago
Neuroscience
Breakthrough Technique Keeps Human Brain Organoids Alive for Five Years, Revolutionizing Disease Study
3 sources · 60d ago
Personalized Oncology
First Personalized mRNA Cancer Vaccine Clears Phase 3 Trial for Melanoma
6 sources · 64d ago
More in Medical Research
Genetic Heart DiseasePreclinical Breakthrough
Gene Therapy Restores Heart Function in Genetic Cardiomyopathy Models, Spares Need for Transplants
Molecular Geneticists 40%Pediatric Cardiology Researchers 35%Clinical Analysts 25%
ExplainerCancer Screening
Single Blood Test Detects 50 Cancers Before Symptoms, But Landmark Trial Shows Mixed Results
Clinical Optimists 55%Evidence Skeptics 30%Factlen Editorial Team 15%
Cardiovascular CareClinical Breakthrough
Centuries-Old Heart Drug Digoxin Slashes Hospitalizations by 25% in Landmark Studies
Clinical Researchers 40%Public Health Advocates 35%Cautious Practitioners 25%
Virtual Cells
GenBio AI Launches 'AIDO Cell,' a Virtual Foundation Model to Simulate Human Biology
Computational Biologists 35%Drug Discovery Industry 35%Experimental Biologists 30%
Synthetic Biology
How AI's Ability to Design and Synthesize Functional Viruses Rewrites the Rules of Biosecurity and Drug Discovery
Biosecurity Advocates 40%Therapeutic Optimists 40%Open-Science Proponents 20%
ExplainerBioethics
Bioethics Debate Intensifies as Experts Warn Gene-Edited Human Technology Requires Reckoning With 'Darker Uses'
Precautionary Bioethicists 45%Therapeutic Proponents 35%Scientific Innovators 20%
Alzheimer's DiagnosticsFDA Approval
FDA Approves Tauklarify, a New Tau-Targeted PET Tracer for Alzheimer's Diagnostic Workup
Clinical Neurologists 40%Diagnostic Developers 35%Medical Researchers 25%
ExplainerOncology Tech
Scientists Engineer Bacteria as 'Trojan Horses' to Smuggle Cancer-Killing Viruses Past Immune Defenses
Synthetic Biologists 40%Oncology Researchers 35%Medical Skeptics 25%
NIH FundingPolicy Explainer
NIH New Grant Awards Decline 63% in 2026 Amid Shift to Multiyear Forward-Funding Policy
Academic Research Institutions 70%Federal Budget Architects 30%
Autoimmune DiseaseClinical Trial Data
Efgartigimod Phase 3 Trial Succeeds in Severe Autoimmune Myositis Subtype
Clinical Investigators 35%Biopharma Analysts 35%Patient Advocates 30%
ExplainerGenomic Sequencing
How New Methods Are Unlocking Decades of Archived Human Tissue for Single-Cell Analysis
Clinical Pathologists 50%Genomic Researchers 50%
Cellular ReprogrammingEvidence Pack
First Human Trial of Cellular Reprogramming Therapy Begins, Targeting Vision Loss
Longevity Researchers 40%Clinical Safety Monitors 35%Ophthalmology Advocates 25%
ExplainerRegulatory Policy
FDA Uses Machine Learning on Standard Lab Results to Replace Missing Biomarker Tests
Regulatory Innovators 40%Clinical Data Scientists 35%Traditional Diagnosticians 25%
Sickle Cell DiseaseMedical Explainer
How CRISPR Gene Editing Is Achieving a Functional Cure for Sickle Cell Disease
Clinical Researchers 40%Patient Advocates 30%Health Equity Analysts 30%
Long COVIDTreatment Breakthrough
Common Antidepressant Fluvoxamine Shows Meaningful Benefit for Long COVID Fatigue in Major Trial
Clinical Researchers 40%Patient Advocates 30%Public Health Pragmatists 30%
Diabetes Care
FDA Approves First Once-Weekly Basal Insulin for Type 2 Diabetes
Clinical Endocrinologists 40%Type 1 Diabetes Advocates 30%Primary Care Providers 30%
Pediatric DiabetesTreatment Trade-Offs
FDA Approves First Drug to Delay Type 1 Diabetes Progression in Children
Early Intervention Advocates 40%Clinical Safety Monitors 35%Medical Researchers 25%
ExplainerNeuromodulation
Personalized, Accelerated TMS Therapy Achieves Depression Remission in Days, Not Months
Clinical Researchers 40%Patient Access Advocates 35%Health Economists 25%
Aging BiologyTrial Watch
Landmark $38M Trial Tests Rapamycin and GLP-1 Drugs to Extend Human Healthspan
Geroscience Researchers 40%Clinical Skeptics 30%Public Health Advocates 30%
ExplainerCOVID-19 Prevention
FDA Approves First Oral Pill to Prevent COVID-19 Infection After Exposure
Clinical Researchers 40%Public Health Officials 30%Pharmaceutical Industry 30%
Cancer Interception
Experimental KRAS Vaccine Shows Early Promise in Preventing Pancreatic Cancer
Preventative Oncologists 40%Immunology Researchers 35%Clinical Trial Methodologists 25%
ExplainerMelanoma Treatment
FDA Grants Accelerated Approval to First Systemic Oncolytic Viral Therapy for Advanced Melanoma
Clinical Oncologists 40%Patient Advocacy Groups 30%Regulatory Watchdogs 30%
Brain AgingMedical Breakthrough
Hidden Immune Shift in Brain's Memory Center Begins at Age 50, Linking Aging to Dementia
Neuroscience Researchers 40%Clinical Practitioners 35%Factlen Editorial Analysis 25%
Genomic BenchmarkingEvidence Pack
Scientists Complete First High-Quality Diploid Human Genome, Revolutionizing Personalized Medicine
Genomic Researchers 40%Clinical Diagnosticians 35%Biotech Industry Analysts 25%
Infectious DiseasePublic Health Alert
Measles Cases in the Americas Hit 22-Year High as PAHO Warns of 'Very High' Regional Risk
Institutional Health Monitors 40%Clinical & Epidemiological Trackers 35%Public Awareness & Policy Advocates 25%
Vaccine InnovationPolicy Decision
FDA Approves First mRNA Flu Vaccine, Signaling New Era for Annual Immunization
Public Health Officials 44%Medical Researchers 39%Vaccine Skeptics 17%
ExplainerMaternal Health
Molecular Breakthrough Identifies Gene Trigger for Preeclampsia, Paving Way for Prevention and Cure
Medical Researchers 50%Maternal Health Advocates 30%Clinical Obstetricians 20%
Synthetic BiologyBiosecurity Watch
Scientists Create First Viruses Designed by AI, Raising Global Biosecurity Alarm
Biosecurity Advocates 40%Synthetic Biologists 30%Medical Researchers 30%
Spinal Cord RepairMedical Breakthrough
Engineered Human Neurons Successfully Rebuild Damaged Spinal Cord Circuits in Landmark Study
Regenerative Medicine Researchers 40%Clinical Neurologists 30%Patient Advocacy Groups 30%
GLP-1 Side EffectsTrade-Off Analysis
AI Analysis of 400,000 Patients Reveals Unreported GLP-1 Side Effects and How to Mitigate Them
Metabolic Health Advocates 40%Clinical Researchers 35%Women's Health Specialists 25%
ExplainerCancer Reversion
Scientists Successfully Reprogram Colon Cancer Cells Back Into Healthy Tissue in Lab Breakthrough
Systems Biologists 35%Clinical Oncologists 35%Commercial Biotech 30%
ExplainerOsteoarthritis
Single Injection Reverses Cartilage Loss in Landmark Osteoarthritis Trial
Regenerative Medicine Researchers 40%Orthopedic Clinicians 35%Health Economists 25%
Research BriefNeuromodulation
Landmark Study: Vagus Nerve Stimulation Provides Sustained Remission for Severe Depression
Clinical Psychiatrists 40%Neuroscience Researchers 40%Health Economists 20%
ExplainerMedical Genetics
Landmark Personalized Base Editing Therapy Cures Infant With Fatal Metabolic Disorder
Clinical Geneticists & Researchers 47%Regulatory & Bioethics Experts 29%Rare Disease Advocates 24%
Kidney DiseaseClinical Breakthrough
Landmark Phase 3 Trial Shows First Drug to Stabilize Kidney Function Decline in IgA Nephropathy Over Two Years
Clinical Researchers 40%Patient Advocates 30%Industry & Market Analysts 30%
Fibromyalgia ResearchMedical Breakthrough
Landmark Genetic Study Redefines Fibromyalgia as Neurological Disorder, Opening New Treatment Paths
Genomics Researchers 35%Patient Advocates 35%Clinical Specialists 30%
Genetic MedicineBreakthrough Explainer
First In-Vivo CRISPR Therapy Achieves Phase 3 Success, Curing Hereditary Angioedema in 62% of Patients
Clinical Researchers 35%Biotech Industry & Investors 35%Patient Advocacy & Medical News 30%
Sleep Apnea
Nightly Pill for Sleep Apnea Awaits FDA Approval After Phase 3 Success
Sleep Medicine Specialists 40%Pharmaceutical Innovators 35%Patient Care Advocates 25%
CRISPR TechScientific Breakthrough
Scientists Shrink CRISPR System to Enable Precision Gene Editing Inside the Body
Gene Therapy Developers 40%Structural Biologists 35%Clinical Translators 25%
ExplainerCancer Screening
FDA Approves First Blood Tests for Colorectal Cancer Screening: How They Work and What They Miss
Gastroenterologists & Oncologists 45%Public Health Advocates 35%Clinical Researchers 20%
Prostate CancerTreatment Explainer
FDA Approves First Radioligand Therapy for Hormone-Sensitive Metastatic Prostate Cancer in Major Oncology Shift
Oncology Specialists 41%Patient Advocacy Groups 29%Industry & Market Analysts 29%
Cell TherapyMedical Breakthrough
Supercharged Natural Killer Cells Overcome Solid Tumor Barrier in Major Immunotherapy Advance
Cellular Immunologists 50%Translational Oncologists 30%Healthcare Systems & Patients 20%
Protein EngineeringScientific Breakthrough
DNA Used as Programmable Scaffold to Assemble Protein Crystals, Revolutionizing Drug Design
Structural Biologists 40%Materials Scientists 35%Pharmaceutical Developers 25%
Research BriefmRNA Oncology
Personalized mRNA Cancer Vaccine Cuts Melanoma Recurrence by 49% in 5-Year Trial
Clinical Oncologists 45%Biotech Innovators 35%Evidence Skeptics 20%
ExplainerAlzheimer's Disease
New Blood Test Achieves 90% Accuracy in Diagnosing Alzheimer’s Disease, Outperforming Standard Methods
Clinical Researchers 40%Primary Care Providers 35%Diagnostics Industry 25%
Research BriefLongevity Science
Landmark $38 Million Trial Launches to Test Rapamycin, Semaglutide, and Dapagliflozin for Healthspan Extension
Geroscience Researchers 40%Clinical Skeptics 30%Regulatory Innovators 30%
Per page